Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives
Authors
Keywords
-
Journal
Frontiers of Medicine
Volume 6, Issue 1, Pages 67-78
Publisher
Springer Nature
Online
2012-03-30
DOI
10.1007/s11684-012-0176-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cudratricusxanthone G inhibits human colorectal carcinoma cell invasion by MMP-2 down-regulation through suppressing activator protein-1 activity
- (2011) Lisha Kuang et al. BIOCHEMICAL PHARMACOLOGY
- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF
- (2011) Charlotte Rolny et al. CANCER CELL
- Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy
- (2011) Yasufumi Sato CANCER SCIENCE
- 1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway
- (2011) X. Pang et al. CARCINOGENESIS
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α
- (2011) Manoj Nepal et al. CELL BIOCHEMISTRY AND FUNCTION
- CD133+ Glioblastoma Stem-Like Cells Induce Vascular Mimicry in Vivo
- (2011) Ming-Tsang Chiao et al. CURRENT NEUROVASCULAR RESEARCH
- Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression
- (2011) Byoungduck Park et al. INTERNATIONAL JOURNAL OF CANCER
- Time-Course Imaging of Therapeutic Functional Tumor Vascular Normalization by Antiangiogenic Agents
- (2011) Q. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Antiangiogenic therapy: impact on invasion, disease progression and metastasis
- (2011) John M. L. Ebos et al. Nature Reviews Clinical Oncology
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Transdifferentiation of glioblastoma cells into vascular endothelial cells
- (2011) Y. Soda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Concise Review: Contribution of Cancer Stem Cells to Neovascularization
- (2011) Yi-Fang Ping et al. STEM CELLS
- From Vessel Sprouting to Normalization
- (2010) Cathy Coulon et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis
- (2010) Dusan Djokovic et al. BMC CANCER
- Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro
- (2010) Yaodong Zhao et al. BRAIN RESEARCH BULLETIN
- Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway
- (2010) X. Pang et al. CANCER RESEARCH
- Down-Regulation of Telomerase Activity and Activation of Caspase-3 Are Responsible for Tanshinone I-Induced Apoptosis in Monocyte Leukemia Cells in Vitro
- (2010) Xiao-Dan Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?
- (2010) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials
- (2010) David Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- Identification of Piwil2-Like (PL2L) Proteins that Promote Tumorigenesis
- (2010) Yin Ye et al. PLoS One
- Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential Pitfalls
- (2010) J. E. Bohonowych et al. Journal of Oncology
- Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature
- (2009) G-One Ahn et al. ANGIOGENESIS
- Ancestral vascular tube formation and its adoption by tumors
- (2009) Tomáš Kučera et al. BIOLOGICAL CHEMISTRY
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Morelloflavone, a Biflavonoid, Inhibits Tumor Angiogenesis by Targeting Rho GTPases and Extracellular Signal-Regulated Kinase Signaling Pathways
- (2009) X. Pang et al. CANCER RESEARCH
- Acetyl-11-Keto- -Boswellic Acid Inhibits Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
- (2009) X. Pang et al. CANCER RESEARCH
- Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
- (2009) Massimiliano Mazzone et al. CELL
- Hypoxia-inducible factor in cancer angiogenesis: Structure, regulation and clinical perspectives
- (2009) Zaher K. Otrock et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Discovery of Antiangiogenic Molecules: A Historical Review
- (2009) Domenico Ribatti CURRENT PHARMACEUTICAL DESIGN
- You Don't Need a PHD to Grow a Tumor
- (2009) Jung-whan Kim et al. DEVELOPMENTAL CELL
- Endothelial differentiation of Wharton's jelly–derived mesenchymal stem cells in comparison with bone marrow–derived mesenchymal stem cells
- (2009) Ming-Yan Chen et al. EXPERIMENTAL HEMATOLOGY
- VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy
- (2009) Joshua I Greenberg et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Role of macrophages in tumour progression
- (2009) K.S. Siveen et al. IMMUNOLOGY LETTERS
- Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects
- (2009) Peter McColgan et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia-inducible Factor-1-mediated Regulation of Semaphorin 4D Affects Tumor Growth and Vascularity
- (2009) Qiangming Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endogenous inhibitors of angiogenesis
- (2009) Domenico Ribatti LEUKEMIA RESEARCH
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Anticancer strategies involving the vasculature
- (2009) Victoria L. Heath et al. Nature Reviews Clinical Oncology
- Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality
- (2009) Quansheng Zhou et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The Role of VE-cadherin in Osteosarcoma Cells
- (2009) Li-Zhi Zhang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Cancer Stem Cells, Hypoxia and Metastasis
- (2009) Richard P. Hill et al. SEMINARS IN RADIATION ONCOLOGY
- Vascular determinants of cancer stem cell dormancy-do age and coagulation system play a role?
- (2008) JANUSZ RAK et al. APMIS
- Structure of artificial and natural VE-cadherinbased adherens junctions
- (2008) Jean-Christophe Taveau et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis
- (2008) H. Chen et al. BLOOD
- Angiogenesis in pre-malignant conditions
- (2008) S R Menakuru et al. BRITISH JOURNAL OF CANCER
- Rapid degradation of hypoxia-inducible factor-1α by KRH102053, a new activator of prolyl hydroxylase 2
- (2008) H J Choi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vascular Endothelial Cadherin Promotes Breast Cancer Progression via Transforming Growth Factor Signaling
- (2008) M. Labelle et al. CANCER RESEARCH
- Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
- (2008) R. Ria et al. CLINICAL CANCER RESEARCH
- Breaking the VE-cadherin bonds
- (2008) Julie Gavard FEBS LETTERS
- The role of adherens junctions and VE-cadherin in the control of vascular permeability
- (2008) E. Dejana et al. JOURNAL OF CELL SCIENCE
- Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine
- (2008) Quansheng Zhou et al. METHODS
- PHD2Mutation and Congenital Erythrocytosis with Paraganglioma
- (2008) Charline Ladroue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precancerous Stem Cells Can Serve As Tumor Vasculogenic Progenitors
- (2008) Rulong Shen et al. PLoS One
- Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia
- (2008) L. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Initiating and Cancer-Propagating Cells in TEL-AML1-Associated Childhood Leukemia
- (2008) D. Hong et al. SCIENCE
- VE-Cadherin
- (2007) Dietmar Vestweber ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study
- (2007) Lei Qiang et al. BIOCHEMICAL PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started